IFNGR1 and melanoma: Compared to the KO of Ifngr1 in endothelial cells, keratinocytes, myeloid immune cells, and melanocytes, only the mouse model that ablated Ifngr1 in fibroblasts could not develop vitiligo under the melanoma-Treg-induced vitiligo model.